Planning Group provides technological know-how of leading life science intermediates companies. The report presents Research Beam Model: Research Beam Product ID: 15839 0 USD New
Life Science Intermediates Market Consolidation: Who will not survive?

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Life Science Intermediates Market Consolidation: Who will not survive?

 
 
 

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- How will the current trends affect the major market segments?

- Which companies will enter the market and which will not survive? This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies. The report presents:




  • Internally developed and acquired technologies, and related capabilities.

  • Proprietary technologies and patent litigations.



The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.



Contains 35 pages